Psomagen, Inc. (KOSDAQ:950200)
South Korea · Delayed Price · Currency is KRW 2,590.00
+180.00 (7.47%)
At close: Jun 29, 2026
Psomagen Market Cap
Psomagen has a market cap or net worth of 49.82 billion as of June 29, 2026. Its market cap has decreased by -35.01% in one year.
Market Cap
49.82B
Enterprise Value
48.77B
Revenue
60.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,590.00
Market Cap Chart
Since July 13, 2020, Psomagen's market cap has decreased from 254.61B to 49.82B, a decrease of -80.43%. That is a compound annual growth rate of -23.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 49.82B | -33.25% |
| Dec 30, 2025 | 74.64B | -4.20% |
| Dec 30, 2024 | 77.91B | -20.59% |
| Dec 28, 2023 | 98.10B | -34.17% |
| Dec 29, 2022 | 149.03B | -12.38% |
| Dec 30, 2021 | 170.10B | -50.35% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Naturalendo Tech | 59.45B |
| PanGen Biotech | 58.52B |
| KoBioLabs | 56.90B |
| IMGT Co.,Ltd. | 56.24B |
| EyeGene | 55.33B |
| TegoScience | 52.12B |
| Progen | 50.12B |
| Parataxis Korea | 44.13B |